Cardiovascular
Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
- Acute Phase Reactants(17)
- Angina(14)
- Arrhythmia(85)
- Atherosclerosis(93)
- Cardiogenesis
- Cardiomyopathy(5)
- Cholesterol Metabolism(46)
- Chronic Kidney Disease(18)
- Coagulation & Hemostasis(131)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(10)
- Endothelium(35)
- Erythrocytes & Hemoglobin(53)
- Heart Failure(32)
- Hypertension(167)
- Hypotension(24)
- Lipoproteins(66)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(64)
- Others(53)
- Serum Proteins(11)
- Smooth Muscle Cells(37)
- Storage & Transport(6)
- Stroke(53)
- Vasoconstriction(61)
- Thrombosis(58)
- Vasodilation(146)
Cardiovascular 相关产品(860)
- GC41580Palmitelaidic Acid methyl esterCAS: 10030-74-7纯度: >98.00%
The trans isomer of palmitoleic acid
- GC41649(±)13-HODE cholesteryl esterCAS: 167354-91-8纯度: >98.00%
A 15-LO product derived from cholesteryl linoleate
- GC41651(±)14(15)-EET-SICAS: 218461-97-3纯度: >95.00%
A potent, metabolically stable analog of 14(15)-EpETrE
- GC41655(±)19(20)-EDP EthanolamideCAS: 2123485-34-5纯度: >98.00%
An ω-3 endocannabinoid epoxide and CB receptor agonist
- GC41661(±)-4-hydroxy Propranolol β-D-GlucuronideCAS: 94731-13-2纯度: >90.00%
A metabolite of propranolol
- GC41666(±)9-HODE cholesteryl esterCAS: 33783-76-5纯度: >98.00%
A racemic monohydroxy fatty acid cholesteryl ester
- GC4189313(R)-HODE cholesteryl esterCAS: 330800-94-7纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
- GC4189513(S)-HODE cholesteryl esterCAS: 141554-21-4纯度: >98.00%
Extracted from atherosclerotic lesions; can be used as a standard
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41483 | 5-hydroxy Propranolol | 81907-82-6 | >98.00% | |
A metabolite of propranolol | ||||
| GC41485 | Digitoxigenin | 143-62-4 | >95.00% | |
A Na + /K + ATPase inhibitor | ||||
| GC41580 | Palmitelaidic Acid methyl ester | 10030-74-7 | >98.00% | |
The trans isomer of palmitoleic acid | ||||
| GC41595 | Matairesinol | 580-72-3 | >95.00% / >98.00% | |
A lignan with diverse biological activities | ||||
| GC41614 | 24-dehydro Cholesterol | 313-04-2 | >98.00% | |
An immediate precursor of cholesterol | ||||
| GC41636 | CAY10487 | 778624-05-8 | >98.00% | |
An antioxidant with anti-atherogenic activity | ||||
| GC41639 | Methyldopate | 6014-30-8 | >95.00% | |
A prodrug form of methyldopa | ||||
| GC41649 | (±)13-HODE cholesteryl ester | 167354-91-8 | >98.00% | |
A 15-LO product derived from cholesteryl linoleate | ||||
| GC41651 | (±)14(15)-EET-SI | 218461-97-3 | >95.00% | |
A potent, metabolically stable analog of 14(15)-EpETrE | ||||
| GC41655 | (±)19(20)-EDP Ethanolamide | 2123485-34-5 | >98.00% | |
An ω-3 endocannabinoid epoxide and CB receptor agonist | ||||
| GC41661 | (±)-4-hydroxy Propranolol β-D-Glucuronide | 94731-13-2 | >90.00% | |
A metabolite of propranolol | ||||
| GC41665 | (±)8(9)-EET Ethanolamide | - | >98.00% | |
A cytochrome P450 metabolite of AEA | ||||
| GC41666 | (±)9-HODE cholesteryl ester | 33783-76-5 | >98.00% | |
A racemic monohydroxy fatty acid cholesteryl ester | ||||
| GC41694 | (3S)-hydroxy Quinidine | 53467-23-5 | >98.00% | |
An active quinidine metabolite | ||||
| GC41696 | (Ala1)-PAR4 (1-6) (mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide agonist of PAR4 | ||||
| GC41697 | (Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide agonist of PAR4 | ||||
| GC41704 | (Glp1)-Apelin-13 (trifluoroacetate salt) | - | >95.00% | |
A potent APJ receptor agonist | ||||
| GC41722 | (R,S)-Carvedilol Glucuronide | 114869-83-9 | >95.00% | |
A phase II metabolite of carvedilol | ||||
| GC41837 | 1,3,7-Trimethyluric Acid | 5415-44-1 | >98.00% | |
A metabolite of caffeine | ||||
| GC41846 | 1,3-Dioctanoyl-2-Oleoyl-rac-glycerol | 109796-58-9 | >98.00% | |
A triacylglycerol | ||||
| GC41882 | 12(S)-HETrE | 72710-10-2 | >98.00% | |
An inhibitor of platelet activation | ||||
| GC41893 | 13(R)-HODE cholesteryl ester | 330800-94-7 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||
| GC41895 | 13(S)-HODE cholesteryl ester | 141554-21-4 | >98.00% | |
Extracted from atherosclerotic lesions; can be used as a standard | ||||
| GC41897 | 13(S)-HOTrE | 87984-82-5 | >98.00% | |
A 15-LO product derived from GLA | ||||